BI
Biocon
BIOCON.NS·NSEBangalore INFounded 197815,000 employees
Mid CapbiotechPublicOncologyImmunologyMetabolic
Platform: Biosimilar Plat
Market Cap
$5B
All Drugs
3
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (BIOCON.NS)
Loading BIOCON.NS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BIO-5105 | BIO-5105 | Phase 3 | 1 | AHR | NMOSD | ||
| BIO-4284 | BIO-4284 | Phase 2/3 | 2 | PSMA | SCDLN | ||
| BIO-8650 | BIO-8650 | Phase 2 | 1 | CGRP | NASH |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Biocon trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)